广誉远(600771) - 2015 Q1 - 季度财报

Financial Performance - Operating revenue rose by 44.89% to CNY 84,254,857.14 year-on-year[7] - Net profit attributable to shareholders improved by 86.11% to a loss of CNY 1,165,208.36 compared to the same period last year[7] - Revenue, cost of goods sold, and business tax increased by 44.89%, 64.22%, and 91.82% respectively compared to the same period last year[14] - The company's operating revenue increased by 44.89% year-on-year, with a growth rate of 82.93% on a comparable basis[15] - Operating profit, total profit, and income tax expenses increased by 964,000 yuan, 905,000 yuan, and 62,000 yuan respectively, with growth rates of 86.93%, 96.79%, and 611.48% due to the aforementioned equity transfer gains[15] - The company reported a significant increase in accounts payable by 182.50% to CNY 7,300,000 due to bank acceptance bills[14] - Total revenue for Q1 2015 was CNY 84,254,857.14, an increase of 44.9% compared to CNY 58,150,798.60 in the same period last year[29] - The company's operating revenue for Q1 2015 was CNY 1,516,294.65, a decrease of approximately 77.6% compared to CNY 6,700,801.80 in the same period last year[32] - The net profit for Q1 2015 was a loss of CNY 1,774,693.45, improving from a loss of CNY 4,041,611.26 in Q1 2014[32] Cash Flow and Liquidity - Cash flow from operating activities improved by 85.87% to a net outflow of CNY 2,434,119.68[7] - Net cash flow from operating activities increased by 1,480,000 yuan, a growth of 85.87%, driven by significant sales revenue growth[16] - Net cash flow from financing activities increased by 438,000 yuan, a rise of 33.66%, primarily due to reduced repayments of borrowings[16] - The net cash flow from operating activities was a loss of CNY 2,434,119.68, an improvement from a loss of CNY 17,231,686.20 in Q1 2014[34] - The total cash outflow from operating activities was CNY 101,935,851.34, compared to CNY 97,632,443.67 in the previous year[34] - The company reported cash and cash equivalents at the end of Q1 2015 of CNY 27,581,533.54, compared to CNY 9,924,661.10 at the end of Q1 2014[35] - The net cash flow from investing activities was CNY 4,098,430.22, compared to CNY 3,345,340.10 in the same period last year[35] - The net cash flow from financing activities was a loss of CNY 8,629,785.11, an improvement from a loss of CNY 13,007,704.82 in Q1 2014[35] - The company received CNY 700,000.00 from other financing activities in Q1 2015[36] Assets and Liabilities - Total assets increased by 5.96% to CNY 489,765,200.97 compared to the end of the previous year[7] - The company's total liabilities were 390,037,982.58 yuan, up from 376,561,727.25 yuan at the start of the year[24] - The company's total assets decreased to CNY 208,719,247.69 from CNY 217,707,623.40 at the beginning of the year[27] - Total liabilities decreased to CNY 170,112,859.71 from CNY 177,326,541.97 at the beginning of the year[27] - The total equity of the company was CNY 38,606,387.98, down from CNY 40,381,081.43 at the beginning of the year[27] Shareholder Information - The number of shareholders reached 13,507, with the largest shareholder holding 22.17% of the shares[11] - The company reduced its stake in Shanxi Guangyuyuan Guoyao Tang Co., Ltd. and Beijing Guangyuyuan Pharmaceutical Investment Co., Ltd. from 51% to 10%[14] Management and Governance - The legal representative is Zhang Bin, indicating the leadership structure of the company[38] - The head of accounting work is Fu Shuhong, responsible for financial oversight[38] - The accounting institution is led by Hou Kuanyu, ensuring compliance and accuracy in financial reporting[38]